一种定量人创伤患者血浆形成血栓中纤维蛋白-纤维蛋白及纤维蛋白-α2-抗纤溶酶交联的新方法
研究开发了基于液相色谱-质谱联用和平行反应监测的方法,定量创伤患者血浆中纤维蛋白-纤维蛋白和纤维蛋白-α2AP交联,避免氨甲环酸干扰。比较冷沉淀和纤维蛋白原浓缩物输注后交联丰度差异,发现冷沉淀组交联显著增加,且交联丰度与纤维蛋白纤维韧性、凝血酶峰值浓度和FXIII抗原正相关。
要点
- 新方法可定量接受氨甲环酸创伤患者血浆中的纤维蛋白交联,间接反映纤溶抵抗。
- 冷沉淀输注后交联丰度显著增加(P < .0001),纤维蛋白原浓缩物输注后未显著增加。
- 交联丰度与纤维蛋白纤维韧性、凝血酶峰值浓度和FXIII抗原正相关(P < .05)。
核心结论
- 开发了一种新方法,可定量接受氨甲环酸的创伤患者中的纤维蛋白交联,提供纤溶抵抗的间接测量。
- 使用该方法避免氨甲环酸影响,显示冷沉淀相比纤维蛋白原浓缩物增加纤维蛋白-纤维蛋白和纤维蛋白-α2AP交联,突出FXIII在创伤患者血凝块形成和稳定性中的重要性。
研究设计与样本
- 使用液相色谱-质谱联用(LC-MS)和平行反应监测定量创伤患者配对血浆样本(纤维蛋白原替代前和替代后)中的FGA-FGA、FGG-FGG和FGA-α2AP交联。
- 分析接受冷沉淀(cryo)或纤维蛋白原浓缩物(Fg-C)的创伤患者交联丰度差异。
主要发现
- 创伤患者冷沉淀输注后交联丰度显著增加(P < .0001),纤维蛋白原浓缩物输注后未显著增加。
- 交联丰度与单个纤维蛋白纤维的韧性、凝血酶峰值浓度和FXIII抗原正相关(P < .05)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The widespread use of the antifibrinolytic agent, tranexamic acid (TXA), interferes with the quantification of fibrinolysis by dynamic laboratory assays such as clot lysis, making it difficult to measure fibrinolysis in many trauma patients. At the final stage of coagulation, factor (F)XIIIa catalyzes the formation of fibrin-fibrin and fibrin-α2-antiplasmin (α2AP) cross-links, which increases clot mechanical strength and resistance to fibrinolysis. OBJECTIVES: Here, we developed a method to quantify fibrin-fibrin and fibrin-α2AP cross-links that avoids the challenges posed by TXA in determining fibrinolytic resistance in conventional assays. METHODS: Fibrinogen alpha (FGA) chain (FGA-FGA), fibrinogen gamma (FGG) chain (FGG-FGG), and FGA-α2AP cross-links were quantified using liquid chromatography-mass spectrometry (LC-MS) and parallel reaction monitoring in paired plasma samples from trauma patients prefibrinogen and postfibrinogen replacement. Differences in the abundance of cross-links in trauma patients receiving cryoprecipitate (cryo) or fibrinogen concentrate (Fg-C) were analyzed. RESULTS: The abundance of cross-links was significantly increased in trauma patients postcryo, but not Fg-C transfusion (P < .0001). The abundance of cross-links was positively correlated with the toughness of individual fibrin fibers, the peak thrombin concentration, and FXIII antigen (P < .05). CONCLUSION: We have developed a novel method that allows us to quantify fibrin cross-links in trauma patients who have received TXA, providing an indirect measure of fibrinolytic resistance. Using this novel approach, we have avoided the effect of TXA and shown that cryo increases fibrin-fibrin and fibrin-α2AP cross-linking when compared with Fg-C, highlighting the importance of FXIII in clot formation and stability in trauma patients.
引用
- Morrow GB, Flannery S, Charles PD, et al. A novel method to quantify fibrin-fibrin and fibrin-α2-antiplasmin cross-links in thrombi formed from human trauma patient plasma. J Thromb Haemost. 2024. PMID: 38462220. doi:10.1016/j.jtha.2024.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。